Today: 29 April 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Range Resources slides as gas prices sink after EIA storage data — what traders watch next

Range Resources slides as gas prices sink after EIA storage data — what traders watch next

Range Resources shares fell 3% to $34.99 after U.S. natural gas futures dropped 6% following a government storage report. The EIA said utilities withdrew 38 billion cubic feet of gas last week, leaving inventories 2% below last year but 2% above the five-year average. EQT, Antero Resources, and CNX Resources also traded lower.
31 December 2025
·····
Lionsgate Studios stock today: LION slides after insider sale filings hit the tape

Lionsgate Studios stock today: LION slides after insider sale filings hit the tape

Lionsgate Studios shares dropped 3.4% to $8.94 midday after SEC filings showed CEO Jon Feltheimer and Vice Chair Michael Burns sold stock in late December for tax planning. Feltheimer sold 195,000 shares at $8.28, Burns sold 21,748 at $9.01. The stock traded between $8.94 and $9.16 on volume of 1.23 million shares. Investors are watching if shares hold below $9 ahead of the next earnings update.
31 December 2025
··
AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

AAON shares dropped 2.7% to $76.48 by midday after the company expanded its revolving credit facility by $100 million, raising total borrowing capacity to $600 million. The move followed use of an “accordion” feature, with other loan terms unchanged. Investors reacted cautiously amid thin year-end trading. The credit line is led by Bank of Oklahoma, Wells Fargo, Bank of America, U.S. Bank, and Associated Bank.
31 December 2025
·
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab A/S shares fell 3.3% to $30.44 in New York after the company dropped further development of acasunlimab, a late-stage cancer drug, following a portfolio review. Genmab said the move does not affect its 2025 guidance and will focus on other pipeline drugs. The company also completed its acquisition of Merus N.V., paying $97 per share in a tender offer. Merus requested Nasdaq delist its stock after the merger.
31 December 2025
···
Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax’s U.S.-listed shares fell 3.8% to $133.04 late Wednesday morning, reversing part of a recent surge driven by takeover speculation and index inclusion. Trading volume reached about 348,000 shares as the stock swung between $132.13 and $140.25. Investors await updates on strategic interest and new data for obefazimod, the company’s lead drug candidate.
31 December 2025
··
Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq kept trading in Platinum Analytics Cayman Limited (PLTS) halted Wednesday, listing the reason as “not available” as of 10:23 a.m. ET. The exchange had previously halted PLTS in October after an SEC suspension and requested more information from the company. No further details were provided in the latest notice. Separately, a Bengaluru renter’s late-night noise complaint on Reddit sparked debate over shared-living boundaries.
31 December 2025
·
Why Life360 stock is sliding today as year-end trading hits tech names

Why Life360 stock is sliding today as year-end trading hits tech names

Life360 shares fell 4.4% to $63.79 in morning Nasdaq trading, down $2.94 from Tuesday’s close, with about 108,000 shares changing hands. The drop came as tech stocks extended losses on the final trading day of 2025. Life360 recently raised its full-year revenue outlook and agreed to buy ad-tech firm Nativo for $120 million. The company’s next earnings report is set for Feb. 26.
31 December 2025
···
XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

XPeng’s U.S.-listed shares fell 6% to $19.99 by late morning in New York on Wednesday, while NIO dropped 9.5% and Li Auto slid 4.8%. Traders cited thin year-end liquidity and awaited January delivery data and details on China’s updated EV subsidies. XPeng’s ADRs traded between $19.87 and $20.54, with volume near 3.9 million shares. Broader U.S. stocks also slipped ahead of the New Year’s holiday.
31 December 2025
·····
1 … 331 332 333 334 335 … 584

Stock Market Today

  • Raymond James Cuts Stantec Target Price Amid Mixed Analyst Ratings
    April 29, 2026, 5:04 PM EDT. Raymond James Financial lowered its target price for Stantec (TSE:STN) from C$180 to C$165, signaling a cautious outlook despite a potential 34.68% upside. Other analysts showed varied sentiments: National Bank Financial and Scotiabank cut targets, while Royal Bank of Canada and Desjardins raised theirs. Stantec's stock traded down 0.4% at C$122.51 with moderate volume. The company posted Q4 earnings of C$0.82 per share on C$2.12 billion revenue. Stantec, specializing in engineering and consulting for infrastructure and sustainability, has a market cap near C$14 billion and holds a Moderate Buy consensus based on nine Buy and one Hold ratings.

Latest article

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

29 April 2026
Nebius Group N.V. shares rose 5.3% to $142.73 Wednesday as Meta Platforms raised its 2026 capital spending forecast by up to $10 billion, citing higher data center costs. Nebius has a contract to supply Meta with up to $27 billion in AI cloud capacity. Fourth-quarter 2025 revenue jumped 547% to $227.7 million, but the company reported a net loss of $249.6 million.
Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

29 April 2026
Phillips 66 reported an adjusted first-quarter profit of $200 million, or 49 cents per share, beating analyst forecasts of a loss. Strong refining margins and 95% plant utilization offset $839 million in hedge-related losses. Shares rose over 6% after the results. The company also completed its acquisition of Lindsey Oil Refinery assets in the UK.
Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

29 April 2026
Extreme Networks shares surged 28% after reporting fiscal Q3 revenue of $316.9 million, up 11%, and non-GAAP earnings of 26 cents per share, both above estimates. The company forecast Q4 revenue of $330–$335 million, topping FactSet’s $326.9 million estimate. SaaS annual recurring revenue rose 28.6% to $236.4 million. Net income climbed to $10.6 million from $3.5 million a year earlier.
Go toTop